🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients

Recruitingn/aAges 21 Years - 99 YearsAllNational Cancer Centre, Singapore
NCT04340024 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with severe side effects from radiotherapy * Patients with a type of cancer that is associated with sensitivity to radiotherapy Exclusion Criteria: * Age of patient must be between 21 (inclusive) and 99 (exclusive)
💊

What it tests

  • Not listed
📍

Where

1 site
National Cancer Center Singapore
Singapore, Singapore
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy